CONTEXT: Down syndrome (DS) is the most common genetic cause of mental retardation. However, the biological determinants of this are poorly understood. The serum sodium/myo-inositol cotransporter gene is located on chromosome 21, and myo-inositol affects neuronal survival and function. Nevertheless, few in vivo studies have examined the role of myo-inositol in DS. OBJECTIVE: To determine if people with DS have significant differences in brain myo-inositol concentration from controls and if, within people with DS, this is related to cognitive ability. DESIGN: A case-control study. SETTING: Outpatient. PARTICIPANTS: The sample was composed of 38 adults with DS without dementia (age range, 18-66 years) and 42 healthy controls (age range, 19-66 years). The DS and control groups did not differ significantly in age, sex, ethnic origin, apolipoprotein E status, or handedness. MAIN OUTCOME MEASURES: Hippocampal myo-inositol concentration and cognitive performance, as measured by the Cambridge Cognitive Examination. RESULTS: Hippocampal myo-inositol concentration was significantly higher in people with DS than in controls (P = .006), and within people with DS, increased myo-inositol concentration was significantly negatively correlated with overall cognitive ability (P = .04). CONCLUSIONS: Adults with DS have a significantly increased brain concentration of myo-inositol, and this is associated with reduced cognitive ability. Future studies are required to relate myo-inositol concentration in people with DS to brain development and increased risk for developing Alzheimer disease.
CONTEXT: Down syndrome (DS) is the most common genetic cause of mental retardation. However, the biological determinants of this are poorly understood. The serum sodium/myo-inositol cotransporter gene is located on chromosome 21, and myo-inositol affects neuronal survival and function. Nevertheless, few in vivo studies have examined the role of myo-inositol in DS. OBJECTIVE: To determine if people with DS have significant differences in brain myo-inositol concentration from controls and if, within people with DS, this is related to cognitive ability. DESIGN: A case-control study. SETTING:Outpatient. PARTICIPANTS: The sample was composed of 38 adults with DS without dementia (age range, 18-66 years) and 42 healthy controls (age range, 19-66 years). The DS and control groups did not differ significantly in age, sex, ethnic origin, apolipoprotein E status, or handedness. MAIN OUTCOME MEASURES: Hippocampal myo-inositol concentration and cognitive performance, as measured by the Cambridge Cognitive Examination. RESULTS: Hippocampal myo-inositol concentration was significantly higher in people with DS than in controls (P = .006), and within people with DS, increased myo-inositol concentration was significantly negatively correlated with overall cognitive ability (P = .04). CONCLUSIONS: Adults with DS have a significantly increased brain concentration of myo-inositol, and this is associated with reduced cognitive ability. Future studies are required to relate myo-inositol concentration in people with DS to brain development and increased risk for developing Alzheimer disease.
Authors: Marquis P Vawter; Abdul Rezzak Hamzeh; Edgar Muradyan; Olivier Civelli; Geoffrey W Abbott; Amal Alachkar Journal: Mol Neuropsychiatry Date: 2019-08-08
Authors: Ana María Cárdenas; Paola Fernández-Olivares; Ignacio Díaz-Franulic; Arlek M González-Jamett; Takeshi Shimahara; Juan Segura-Aguilar; Raúl Caviedes; Pablo Caviedes Journal: Neurotox Res Date: 2017-07-10 Impact factor: 3.911
Authors: Ratnam S Seelan; M Michele Pisano; Robert M Greene; Manuel F Casanova; Ranga N Parthasarathy Journal: Epigenomics Date: 2011-02 Impact factor: 4.778
Authors: Fabiana da Silva Alves; Erik Boot; Nicole Schmitz; Aart Nederveen; Jacob Vorstman; Christina Lavini; Petra J Pouwels; Petra Pouwels; Lieuwe de Haan; Don Linszen; Therese van Amelsvoort Journal: PLoS One Date: 2011-06-30 Impact factor: 3.240
Authors: Susana de Sola; Rafael de la Torre; Gonzalo Sánchez-Benavides; Bessy Benejam; Aida Cuenca-Royo; Laura Del Hoyo; Joan Rodríguez; Silvina Catuara-Solarz; Judit Sanchez-Gutierrez; Ivan Dueñas-Espin; Gimena Hernandez; Jordi Peña-Casanova; Klaus Langohr; Sebastia Videla; Henry Blehaut; Magi Farre; Mara Dierssen Journal: Front Psychol Date: 2015-06-04
Authors: Jeffrey S Anderson; Jared A Nielsen; Michael A Ferguson; Melissa C Burback; Elizabeth T Cox; Li Dai; Guido Gerig; Jamie O Edgin; Julie R Korenberg Journal: Neuroimage Clin Date: 2013-05-24 Impact factor: 4.881